Detalhe da pesquisa
1.
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist.
PLoS Pathog
; 17(5): e1009576, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34015061
2.
Cross neutralization of SARS-CoV-2 omicron subvariants after repeated doses of COVID-19 mRNA vaccines.
J Med Virol
; 95(1): e28268, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36319593
3.
Superior neutralizing response after first versus second SARS-CoV-2 infection in fully vaccinated individuals.
J Med Virol
; 95(11): e29225, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37971751
4.
Potent Neutralizing Activity of Polyclonal Equine Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern.
J Infect Dis
; 227(1): 35-39, 2022 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921532
5.
Neutralizing Response Against SARS-CoV-2 Variants 8 Months After BNT162b2 Vaccination in Naive and COVID-19-Convalescent Individuals.
J Infect Dis
; 225(11): 1905-1908, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34963008
6.
Template-primer binding affinity and RNase H cleavage specificity contribute to the strand transfer efficiency of HIV-1 reverse transcriptase.
J Biol Chem
; 293(35): 13351-13363, 2018 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29991591
7.
Unprecedented Thiacalixarene Fucoclusters as Strong Inhibitors of Ebola cis-Cell Infection and HCMV-gB Glycoprotein/DC-SIGN C-type Lectin Interaction.
Bioconjug Chem
; 30(4): 1114-1126, 2019 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30912645
8.
Design, synthesis and biological evaluation of 3-hydroxyquinazoline-2,4(1H,3H)-diones as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and integrase.
Bioorg Med Chem
; 27(17): 3836-3845, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31324562
9.
Broad Neutralizing Activity Against Ebolaviruses Lacking the Mucin-Like Domain in Convalescent Plasma Specimens From Patients With Ebola Virus Disease.
J Infect Dis
; 218(suppl_5): S574-S581, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29939289
10.
Nanocarbon-Based Glycoconjugates as Multivalent Inhibitors of Ebola Virus Infection.
J Am Chem Soc
; 140(31): 9891-9898, 2018 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30014698
11.
Immune Response Against SARS-CoV-2 Infection and Vaccination in a CD8α-Deficient Patient.
J Clin Immunol
; 43(6): 1072-1074, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37145391
12.
Convalescent Plasma for Ebola Virus Disease.
N Engl J Med
; 374(25): 2498-9, 2016 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27332914
13.
Correction to Unprecedented Thiacalixarene Fucoclusters as Strong Inhibitors of Ebola cis-Cell Infection and HCMV-gB Glycoprotein/DC-SIGN C-type Lectin Interaction.
Bioconjug Chem
; 30(6): 1830-1831, 2019 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31074621
14.
Glycofullerenes inhibit viral infection.
Biomacromolecules
; 14(2): 431-7, 2013 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23281578
15.
The role of DC-SIGN as a trans-receptor in infection by MERS-CoV.
Front Cell Infect Microbiol
; 13: 1177270, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37808906
16.
TLR7 Activation in M-CSF-Dependent Monocyte-Derived Human Macrophages Potentiates Inflammatory Responses and Prompts Neutrophil Recruitment.
J Innate Immun
; 15(1): 517-530, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37040733
17.
Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates.
Front Immunol
; 14: 1264323, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38155964
18.
MAFB shapes human monocyte-derived macrophage response to SARS-CoV-2 and controls severe COVID-19 biomarker expression.
JCI Insight
; 8(24)2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37917179
19.
Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2.
Adv Sci (Weinh)
; 10(34): e2304818, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37863812
20.
Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses.
Front Immunol
; 13: 981350, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36059485